Nature's Parkin experiment: Nix—a novel protective mechanism in Parkinson's disease

D. Olszewska,T. Lynch

DOI: https://doi.org/10.1002/mds.27015

IF: 9.698

2017-07-01

Movement Disorders

Abstract:Mitophagy, mitochondrial dysfunction, proteasome and lysosome dysfunction, and protein misfolding have key roles in the pathogenesis of Parkinson’s disease (PD). Mitophagy is a mitochondrial housekeeping mechanism mediated by PTEN-induced putative kinase 1 (PINK1) kinase and Parkin ligase. Loss-of-function PINK1 and Parkin mutations cause deregulation of mitophagy and young-onset PD. Parkin was thought to be key to selective mitochondria degradation by autophagy (mitophagy). However, recent studies have emphasized PINK1’s role; autophagy receptors nuclear dot protein 52 kDa (NDP-52) and optineurin can induce mitophagy in Parkin’s absence, but require PINK1. Koentjoro and colleagues report another novel mitophagy pathway, independent of the Parkin/PINK1 pathway by taking advantage of a natural experiment. They studied an asymptomatic woman in her 70s with a homozygous parkin mutation and her symptomatic daughter with a compound heterozygous parkin mutation. Why was the homozygous parkin mutation carrier spared parkinsonism? Through a series of experiments in human cell lines from the asymptomatic carrier, the affected daughter, 2 patients with Parkinrelated PD, and 2 PINK1-related PD, the authors found a protective mechanism in the asymptomatic mother that prevented her from developing PD despite functional Parkin loss. Although the Parkin mutation status differed between the mother and the daughter, functional Parkin loss (absence) was present in both. Mitophagy in the asymptomatic carrier (mother) cell lines was normal as Adenosine triphosphate (ATP) production rate and resistance to the mitochondrial complex 1 inhibitor-rotenone was the same in the carrier and normal control. The absence of PINK1 did not affect Parkin-independent mitophagy in the asymptomatic carrier cells treated with mitophagy inductor (CCCP). PINK1 expression was reduced in asymptomatic carrier cells, regardless of carbonyl cyanide m-chlorophenylhydrazone (CCCP), suggesting the presence of a protective PINK1/Parkin independent mechanism. The authors then studied Nix, which is the selective autophagic receptor Nip3-like protein X that mediates mitophagy in mice fibroblasts, rescues drosophila flies with PINK1 mutations, and acts as a parkin substrate in Human embryonic kidney cells 293 (HEK293A) cells. Although Nix also has a role in Parkin ligase translocation for the ubiquitination (mitochondrial labelling), the authors demonstrated Nixinduced mitophagy with Parkin functional loss. Nix levels were significantly higher in the asymptomatic mother when compared with the affected daughter and control. Mitophagy (CCCP induced) was absent when Nix was silenced. Moreover, Nix overexpression increased the ATP synthesis in Parkin and PINK1 cells, restored mitophagy (CCCP induced), and led to functional enhancement. Studies involving mechanisms affecting vesicular transport and mitochondrial clearance are ongoing. Nix may be useful in PD therapeutics once its exact action mechanism in this setting is known.